Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis

Jon Lykkegaard Andersen; Jakob Sidenius Johansen; Edyta Maria Urbanska; Peter Meldgaard; Peter Hjorth-Hansen; Charlotte Kristiansen; Miroslaw Stelmach; Eric Santoni-Rugiu; Maiken Parm Ulhøi; Betina Højgaard; Morten Sall Jensen; Anders Bondo Dydensborg; Christina Duenweber; Karin Holmskov Hansen

doi:10.2217/lmt-2023-0013

Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis

Jon Lykkegaard Andersen
, Jakob Sidenius Johansen
, Edyta Maria Urbanska
, Peter Meldgaard
, Peter Hjorth-Hansen
, Charlotte Kristiansen
, Miroslaw Stelmach
, Eric Santoni-Rugiu
, Maiken Parm Ulhøi
, Betina Højgaard
, Morten Sall Jensen
, Anders Bondo Dydensborg^*
, Christina Duenweber
, Karin Holmskov Hansen

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

1 Citationer (Scopus)

34 Downloads (Pure)

Abstract

Aim: The main purpose of the present study was to investigate the labor market affiliation of ALK+ NSCLC patients in long-term treatment as well as overall survival and incidence/prevalence. Materials & methods: Nationwide retrospective study of all patients with ALK+ NSCLC in Denmark diagnosed between 2012 and 2018. Results: During the study period ALK+ NSCLC patients had a median overall survival of 44.0 months and a 7.8-fold increase in disease prevalence. Six months prior to diagnosis, 81% of ALK+ NSCLC patients ≤60 years of age were employed. At the end of the 18-month follow-up period, 36% were employed. Conclusion:ALK+ NSCLC patients have prolonged survival following diagnosis, but a large fraction of patients lose affiliation with the labor market.

Originalsprog	Engelsk
Artikelnummer	LMT68
Tidsskrift	Lung cancer management
Vol/bind	13
Udgave nummer	1
Antal sider	11
ISSN	1758-1966
DOI	https://doi.org/10.2217/lmt-2023-0013
Status	Udgivet - 2024

Bibliografisk note

Adgang til dokumentet

10.2217/lmt-2023-0013Licens: CC BY-NC-ND 4.0

Andersen et al. (2024). Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosisForlagets udgivne version, 2,05 MBLicens: CC BY-NC-ND 4.0

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Andre filer og links

Link to publication in Scopus

Citationsformater

Andersen, J. L., Johansen, J. S., Urbanska, E. M., Meldgaard, P., Hjorth-Hansen, P., Kristiansen, C., Stelmach, M., Santoni-Rugiu, E., Ulhøi, M. P., Højgaard, B., Jensen, M. S., Dydensborg, A. B., Duenweber, C., & Hansen, K. H. (2024). Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis. Lung cancer management, 13(1), Artikel LMT68. https://doi.org/10.2217/lmt-2023-0013

@article{143bc3fcde294b2dabb2b12cd5eb953f,

title = "Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis",

abstract = "Aim: The main purpose of the present study was to investigate the labor market affiliation of ALK+ NSCLC patients in long-term treatment as well as overall survival and incidence/prevalence. Materials \& methods: Nationwide retrospective study of all patients with ALK+ NSCLC in Denmark diagnosed between 2012 and 2018. Results: During the study period ALK+ NSCLC patients had a median overall survival of 44.0 months and a 7.8-fold increase in disease prevalence. Six months prior to diagnosis, 81\% of ALK+ NSCLC patients ≤60 years of age were employed. At the end of the 18-month follow-up period, 36\% were employed. Conclusion:ALK+ NSCLC patients have prolonged survival following diagnosis, but a large fraction of patients lose affiliation with the labor market.",

keywords = "ALK+, labor market affiliation, nationwide, non-small-cell lung cancer, prevalence, retrospective, return to work",

author = "Andersen, \{Jon Lykkegaard\} and Johansen, \{Jakob Sidenius\} and Urbanska, \{Edyta Maria\} and Peter Meldgaard and Peter Hjorth-Hansen and Charlotte Kristiansen and Miroslaw Stelmach and Eric Santoni-Rugiu and Ulh{\o}i, \{Maiken Parm\} and Betina H{\o}jgaard and Jensen, \{Morten Sall\} and Dydensborg, \{Anders Bondo\} and Christina Duenweber and Hansen, \{Karin Holmskov\}",

note = "{\textcopyright} 2024 The Author(s). Published by Informa UK Limited, trading as Taylor \& Francis Group.",

year = "2024",

doi = "10.2217/lmt-2023-0013",

language = "English",

volume = "13",

journal = "Lung cancer management",

issn = "1758-1966",

publisher = "Taylor \& Francis",

number = "1",

}

Andersen, JL, Johansen, JS, Urbanska, EM, Meldgaard, P, Hjorth-Hansen, P, Kristiansen, C, Stelmach, M, Santoni-Rugiu, E, Ulhøi, MP, Højgaard, B, Jensen, MS, Dydensborg, AB, Duenweber, C & Hansen, KH 2024, 'Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis', Lung cancer management, bind 13, nr. 1, LMT68. https://doi.org/10.2217/lmt-2023-0013

TY - JOUR

T1 - Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis

AU - Andersen, Jon Lykkegaard

AU - Johansen, Jakob Sidenius

AU - Urbanska, Edyta Maria

AU - Meldgaard, Peter

AU - Hjorth-Hansen, Peter

AU - Kristiansen, Charlotte

AU - Stelmach, Miroslaw

AU - Santoni-Rugiu, Eric

AU - Ulhøi, Maiken Parm

AU - Højgaard, Betina

AU - Jensen, Morten Sall

AU - Dydensborg, Anders Bondo

AU - Duenweber, Christina

AU - Hansen, Karin Holmskov

PY - 2024

Y1 - 2024

N2 - Aim: The main purpose of the present study was to investigate the labor market affiliation of ALK+ NSCLC patients in long-term treatment as well as overall survival and incidence/prevalence. Materials & methods: Nationwide retrospective study of all patients with ALK+ NSCLC in Denmark diagnosed between 2012 and 2018. Results: During the study period ALK+ NSCLC patients had a median overall survival of 44.0 months and a 7.8-fold increase in disease prevalence. Six months prior to diagnosis, 81% of ALK+ NSCLC patients ≤60 years of age were employed. At the end of the 18-month follow-up period, 36% were employed. Conclusion:ALK+ NSCLC patients have prolonged survival following diagnosis, but a large fraction of patients lose affiliation with the labor market.

AB - Aim: The main purpose of the present study was to investigate the labor market affiliation of ALK+ NSCLC patients in long-term treatment as well as overall survival and incidence/prevalence. Materials & methods: Nationwide retrospective study of all patients with ALK+ NSCLC in Denmark diagnosed between 2012 and 2018. Results: During the study period ALK+ NSCLC patients had a median overall survival of 44.0 months and a 7.8-fold increase in disease prevalence. Six months prior to diagnosis, 81% of ALK+ NSCLC patients ≤60 years of age were employed. At the end of the 18-month follow-up period, 36% were employed. Conclusion:ALK+ NSCLC patients have prolonged survival following diagnosis, but a large fraction of patients lose affiliation with the labor market.

KW - ALK+

KW - labor market affiliation

KW - nationwide

KW - non-small-cell lung cancer

KW - prevalence

KW - retrospective

KW - return to work

UR - https://www.scopus.com/pages/publications/85193511476

U2 - 10.2217/lmt-2023-0013

DO - 10.2217/lmt-2023-0013

M3 - Journal article

C2 - 38818369

SN - 1758-1966

VL - 13

JO - Lung cancer management

JF - Lung cancer management

IS - 1

M1 - LMT68

ER -

Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis

Abstract

Bibliografisk note

Adgang til dokumentet

AUB Link

Andre filer og links

Fingeraftryk

Citationsformater